DEXCOM, INC. (DXCM) Operating Margin
- Operating margin · 12 months: Value 22.92%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 22.92% | Operating income / revenue. Period ending 2026-06-30. $1.14B ÷ $4.97B × 100 ≈ 22.92% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.14B USD | Operating Income (Loss) |
| Revenue | 4.97B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.86B USD | Cost of Goods and Services Sold |
| Research and development | 604.00M USD | Research and Development Expense |
| Selling, general and administration | 1.36B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.14B | $4.97B | $1.86B | $604.00M | $1.36B | 22.92% |
| 2026-03-31 | $1.03B | $4.82B | $1.85B | $599.20M | $1.33B | 21.45% |
| 2025-12-31 | $911.80M | $4.66B | $1.86B | $599.10M | $1.29B | 19.56% |
| 2025-09-30 | $777.70M | $4.52B | $1.85B | $590.40M | $1.30B | 17.22% |
| 2025-06-30 | $687.20M | $4.30B | $1.77B | $568.30M | $1.27B | 15.98% |
| 2025-03-31 | $632.60M | $4.15B | $1.68B | $556.10M | $1.28B | 15.25% |
| 2024-12-31 | $600.00M | $4.03B | $1.59B | $552.40M | $1.29B | 14.88% |
| 2024-09-30 | $628.00M | $3.95B | $1.51B | $549.00M | $1.26B | 15.88% |
| 2024-06-30 | $681.50M | $3.93B | $1.47B | $545.00M | $1.24B | 17.32% |
| 2024-03-31 | $651.60M | $3.80B | $1.41B | $528.30M | $1.21B | 17.14% |
| 2023-12-31 | $597.70M | $3.62B | $1.33B | $505.80M | $1.19B | 16.50% |
| 2023-09-30 | $506.20M | $3.40B | $1.23B | $486.00M | $1.17B | 14.88% |
| 2023-06-30 | $448.20M | $3.20B | $1.15B | $464.90M | $1.12B | 14.02% |
| 2023-03-31 | $397.10M | $3.02B | $1.07B | $467.30M | $1.08B | 13.14% |
| 2022-12-31 | $391.20M | $2.91B | $1.03B | $484.20M | $1.00B | 13.44% |
| 2022-09-30 | $266.40M | $2.79B | $978.40M | $517.70M | $939.80M | 9.54% |
| 2022-06-30 | $237.20M | $2.67B | $906.30M | $536.20M | $903.70M | 8.87% |
| 2022-03-31 | $261.20M | $2.57B | $837.60M | $543.60M | $842.80M | 10.15% |
| 2021-12-31 | $265.80M | $2.45B | $768.00M | $517.10M | $810.50M | 10.86% |
| 2021-09-30 | $369.20M | $2.32B | $712.20M | $486.50M | $751.30M | 15.92% |
| 2021-06-30 | $345.00M | $2.17B | $669.40M | $445.40M | $710.10M | 15.90% |
| 2021-03-31 | $311.80M | $2.03B | $659.10M | $396.20M | $659.50M | 15.39% |
| 2020-12-31 | $299.50M | $1.93B | $646.60M | $359.90M | $620.70M | 15.54% |
| 2020-09-30 | $297.00M | $1.82B | $630.30M | $319.50M | $573.80M | 16.31% |
| 2020-06-30 | $258.90M | $1.72B | $619.20M | $298.50M | $539.40M | 15.09% |
| 2020-03-31 | $190.30M | $1.60B | $581.40M | $287.60M | $541.30M | 11.89% |
| 2019-12-31 | $142.30M | $1.48B | $544.50M | $273.50M | $515.70M | 9.64% |
| 2019-09-30 | $-123.80M | $1.35B | $506.20M | $252.30M | $498.80M | -9.16% |
| 2019-06-30 | $-165.90M | $1.22B | $454.90M | $235.70M | $479.20M | -13.58% |
| 2019-03-31 | $-170.00M | $1.13B | $413.90M | $213.90M | $452.20M | -15.07% |
| 2018-12-31 | $-186.30M | $1.03B | $367.70M | $199.70M | $432.80M | -18.06% |
| 2018-09-30 | $-9.70M | $914.60M | (m) | $190.80M | $413.50M | -1.06% |
| 2018-06-30 | $-24.10M | $832.50M | (m) | $184.00M | $393.10M | -2.89% |
| 2018-03-31 | $-32.80M | $760.60M | (m) | $182.10M | $367.60M | -4.31% |
| 2017-12-31 | $-42.50M | $718.50M | (m) | $185.40M | $349.20M | -5.92% |
| 2017-09-30 | $-60.60M | $668.70M | (m) | $180.40M | $335.50M | -9.06% |
| 2017-06-30 | $-78.60M | $632.70M | (m) | $181.00M | $327.00M | -12.42% |
| 2017-03-31 | $-85.10M | $599.40M | (m) | $172.00M | $310.50M | -14.20% |
| 2016-12-31 | $-63.90M | $573.30M | (m) | $156.10M | $286.20M | -11.15% |
| 2016-09-30 | $-56.20M | $532.90M | (m) | $140.90M | $268.20M | -10.55% |
| 2016-06-30 | $-80.10M | $489.50M | (m) | $161.80M | $244.80M | -16.36% |
| 2016-03-31 | $-63.60M | (m) | (m) | $149.90M | $220.70M | (m) |
| 2015-12-31 | $-57.10M | $402.00M | (m) | $137.50M | $198.00M | -14.20% |
| 2015-09-30 | $-57.10M | $355.50M | (m) | $130.60M | $173.10M | -16.06% |
| 2015-06-30 | $-19.70M | $319.30M | (m) | $84.30M | $154.50M | -6.17% |
| 2015-03-31 | $-21.90M | $284.90M | (m) | $74.70M | $140.20M | -7.69% |
| 2014-12-31 | $-21.50M | $259.20M | (m) | $69.40M | $128.40M | -8.29% |
| 2014-09-30 | $-25.40M | $226.60M | (m) | $60.40M | $116.00M | -11.21% |
| 2014-06-30 | $-26.20M | $200.50M | (m) | $53.70M | $103.90M | -13.07% |
| 2014-03-31 | $-30.30M | $177.50M | (m) | $50.00M | $93.70M | -17.07% |
| 2013-12-31 | $-28.90M | $160.00M | (m) | $44.80M | $84.20M | -18.06% |
| 2013-09-30 | $-34.90M | $141.60M | (m) | $42.00M | $76.50M | -24.65% |
| 2013-06-30 | $-46.40M | $121.80M | (m) | $40.40M | $70.40M | -38.10% |
| 2013-03-31 | $-51.20M | $109.40M | (m) | $39.40M | $65.50M | -46.80% |
| 2012-12-31 | $-55.70M | $99.90M | (m) | $39.50M | $62.80M | -55.76% |
| 2012-09-30 | $-59.64M | $89.06M | (m) | $40.03M | $59.34M | -66.97% |
| 2012-06-30 | $-55.63M | $84.22M | (m) | $37.68M | $57.44M | -66.05% |
| 2012-03-31 | $-48.37M | $82.19M | (m) | $34.19M | $54.29M | -58.85% |
| 2011-12-31 | $-44.84M | $76.27M | (m) | $30.75M | $49.94M | -58.80% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $53.26M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-45.29M | $48.63M | (m) | $23.23M | $40.51M | -93.13% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-45.83M | $29.69M | (m) | $14.29M | $35.20M | -154.36% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |